162 related articles for article (PubMed ID: 1457988)
1. Expression of neuronal and glial markers in so-called oligodendroglial tumors induced by transplacental administration of ethyl-nitrosourea in the rat.
Vaquero J; Coca S; Moreno M; Oya S; Arias A; Zurita M; Morales C
Histol Histopathol; 1992 Oct; 7(4):647-51. PubMed ID: 1457988
[TBL] [Abstract][Full Text] [Related]
2. Experimental neurocytomas.
Vaquero J; Coca S; Zurita M; Oya S; Arias A; Morales C; Buján J; García N
Histol Histopathol; 1993 Jan; 8(1):91-6. PubMed ID: 7680251
[TBL] [Abstract][Full Text] [Related]
3. Synaptophysin expression in "ependymal tumors" induced by ethyl-nitrosourea in rats.
Vaquero J; Coca S; Zurita M; Oya S; Arias A; Moreno M; Morales C
Am J Pathol; 1992 Nov; 141(5):1037-41. PubMed ID: 1443043
[TBL] [Abstract][Full Text] [Related]
4. Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway.
Phi JH; Park SH; Kim SK; Paek SH; Kim JH; Lee YJ; Cho BK; Park CK; Lee DH; Wang KC
Am J Surg Pathol; 2008 Jan; 32(1):103-12. PubMed ID: 18162777
[TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical study of ethylnitrosourea-induced rat gliomas with vimentin and astroprotein (GFAP)].
Maruno M; Yoshimine T; Ushio Y; Hayakawa T; Jamshid J; Bitoh S; Mogami H
No To Shinkei; 1985 Dec; 37(12):1173-9. PubMed ID: 4091986
[TBL] [Abstract][Full Text] [Related]
6. Aberrant nestin expression during ethylnitrosourea-(ENU)-induced neurocarcinogenesis.
Jang T; Litofsky NS; Smith TW; Ross AH; Recht LD
Neurobiol Dis; 2004 Apr; 15(3):544-52. PubMed ID: 15056462
[TBL] [Abstract][Full Text] [Related]
7. Glycosaminoglycans of brain tumors transplacentally induced by ENU in the rat.
Giordana MT; Mauro A; Schiffer D
Acta Neuropathol Suppl; 1981; 7():79-80. PubMed ID: 6939289
[TBL] [Abstract][Full Text] [Related]
8. Glial fibrillary acidic protein (GFAP) in rat brain tumors transplacentally induced by ethylnitrosourea (ENU).
Mauro A; Giordana MT; Migheli A; Schiffer D
J Neurol Sci; 1983; 61(3):349-55. PubMed ID: 6361219
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical characterization of pineocytomas.
Coca S; Vaquero J; Escandon J; Moreno M; Peralba J; Rodriguez J
Clin Neuropathol; 1992; 11(6):298-303. PubMed ID: 1473313
[TBL] [Abstract][Full Text] [Related]
10. Expression of oligodendrocytic mRNAs in glial tumors: changes associated with tumor grade and extent of neoplastic infiltration.
Landry CF; Verity MA; Cherman L; Kashima T; Black K; Yates A; Campagnoni AT
Cancer Res; 1997 Sep; 57(18):4098-104. PubMed ID: 9307299
[TBL] [Abstract][Full Text] [Related]
11. Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors.
Janss AJ; Yachnis AT; Silber JH; Trojanowski JQ; Lee VM; Sutton LN; Perilongo G; Rorke LB; Phillips PC
Ann Neurol; 1996 Apr; 39(4):481-9. PubMed ID: 8619526
[TBL] [Abstract][Full Text] [Related]
12. Morphological and immunohistochemical evidence for the presence of subcortical target cells of N-ethyl-N-nitrosourea-induced cerebellar tumors in rats.
Naito M; Aoyama H; Naito Y; Fujioka Y; Ito A
Cancer Res; 1986 Nov; 46(11):5836-41. PubMed ID: 3756925
[TBL] [Abstract][Full Text] [Related]
13. [Differentiation in primitive neuroectodermal tumors. Significance of histology and immunohistochemistry for differential diagnosis].
Grieshammer T
Zentralbl Pathol; 1991; 137(1):57-65. PubMed ID: 1647814
[TBL] [Abstract][Full Text] [Related]
14. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
[TBL] [Abstract][Full Text] [Related]
15. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
Preusser M; Budka H; Rössler K; Hainfellner JA
Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical observations on rat radial glia: relationship with the origin of ethylnitrosourea-induced tumors.
Giordana MT; Migheli A; Mocellini C; Villare F; Schiffer D
Acta Neuropathol; 1992; 84(4):387-93. PubMed ID: 1441920
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical studies on cellular character of microtumors induced by ethylnitrosourea in the rat brain utilizing anti-Leu 7 and anti-glial fibrillary acidic protein antibodies.
Yoshino T; Motoi M; Ogawa K
Acta Neuropathol; 1985; 66(2):167-9. PubMed ID: 2990142
[TBL] [Abstract][Full Text] [Related]
18. Developmental expression of neural cell type-specific mRNA markers in the myelin-deficient mutant rat brain: inhibition of oligodendrocyte differentiation.
Kumar S; Gordon MN; Espinosa de los Monteros MA; de Vellis J
J Neurosci Res; 1988; 21(2-4):268-74. PubMed ID: 2464079
[TBL] [Abstract][Full Text] [Related]
19. Value and limits of immunohistochemistry in differential diagnosis of clear cell primary brain tumors.
Koperek O; Gelpi E; Birner P; Haberler C; Budka H; Hainfellner JA
Acta Neuropathol; 2004 Jul; 108(1):24-30. PubMed ID: 15108012
[TBL] [Abstract][Full Text] [Related]
20. Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas.
Kreiger PA; Okada Y; Simon S; Rorke LB; Louis DN; Golden JA
Acta Neuropathol; 2005 Apr; 109(4):387-92. PubMed ID: 15739101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
